Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 52330 [2011-21420]
Download as PDF
52330
Federal Register / Vol. 76, No. 162 / Monday, August 22, 2011 / Notices
program partners/collaborators
identified by each Program Director (1–
2 partners per Director) as instrumental
to the selection and implementation of
cancer control EBPs. The survey results
will help CDC enhance existing NCCCP
efforts by identifying new strategies for
promoting the use of evidence-based
approaches to comprehensive cancer
control. The surveys will also identify
future studies. CDC’s authorization to
conduct the study is provided by
Section 301 of the Public Health Service
Act (42 U.S.C. 241).
OMB approval will be requested for
one year. Participation in the study is
voluntary. There are no costs to the
respondents other than their time.
technical assistance needs of NCCCPfunded awardees related to selection
and implementation of EBPs, and will
contribute to CDC’s efforts to build the
capacities of states, Tribes, and Pacific
Island Jurisdictions and territories
toward more effective efforts in cancer
prevention and control. Finally, the
results may lead to new insights and
questions that can be addressed in
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
CCC Program Directors ...........
Total ..........................................
...................................................................
Catina Conner,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–21400 Filed 8–19–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Member Conflict Review,
Program Announcement (PA) 07–318,
initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
jlentini on DSK4TPTVN1PROD with NOTICES
Number of responses per
respondent
66
66
1
1
15/60
0.5
17
33
66
1
20/60
22
132
1
0.5
66
........................
........................
........................
138
Survey Scheduling Script .........................
Program Directors Web Survey Questionnaire.
Program Directors Telephone Interview
Guide and Script.
Program Partners Web Survey Questionnaire.
CCC Program Partners ............
Time and Date: 1 p.m.–3 p.m., November
9, 2011 (Closed).
Place: National Institute for Occupational
Safety and Health (NIOSH), CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26506, Telephone: (304) 285–6143.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Member Conflict Review, PA
07–318.’’
VerDate Mar<15>2010
18:50 Aug 19, 2011
Jkt 223001
Contact Person for More Information:
Bernadine Kuchinski, PhD, Scientific Review
Officer, Office of Extramural Programs,
NIOSH, CDC, Robert A. Taft Laboratories,
4676 Columbia Parkway, MS C–7, Cincinnati,
Ohio 45226, Telephone: (513) 533–8511.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: August 12, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2011–21420 Filed 8–19–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
8 a.m.–5 p.m., October 18, 2011 (Closed).
8 a.m.–5 p.m., October 19, 2011 (Closed).
PO 00000
Frm 00028
Average burden per response
(in hours)
Number of respondents
Type of Respondent
Fmt 4703
Sfmt 4703
Total response
burden
(in hours)
Place: Embassy Suites, 1900 Diagonal
Road, Alexandria, Virginia 22314,
Telephone: (703) 684–5900, Fax: (703) 684–
0653.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and the
Determination of the Director, Management
Analysis and Services Office, CDC, pursuant
to Public Law 92–463.
Purpose: The Safety and Occupational
Health Study Section will review, discuss,
and evaluate grant application(s) received in
response to the Institute’s standard grants
review and funding cycles pertaining to
research issues in occupational safety and
health, and allied areas.
It is the intent of NIOSH to support broadbased research endeavors in keeping with the
Institute’s program goals. This will lead to
improved understanding and appreciation for
the magnitude of the aggregate health burden
associated with occupational injuries and
illnesses, as well as to support more focused
research projects, which will lead to
improvements in the delivery of occupational
safety and health services, and the
prevention of work-related injury and illness.
It is anticipated that research funded will
promote these program goals.
Matters To Be Discussed: The meeting will
convene to address matters related to the
conduct of Study Section business and for
the study section to consider safety and
occupational health-related grant
applications.
These portions of the meeting will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5 U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention, pursuant to Section 10(d)
Pub. L. 92–463.
E:\FR\FM\22AUN1.SGM
22AUN1
Agencies
[Federal Register Volume 76, Number 162 (Monday, August 22, 2011)]
[Notices]
[Page 52330]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21420]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Member Conflict Review,
Program Announcement (PA) 07-318, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 1 p.m.-3 p.m., November 9, 2011 (Closed).
Place: National Institute for Occupational Safety and Health
(NIOSH), CDC, 1095 Willowdale Road, Morgantown, West Virginia 26506,
Telephone: (304) 285-6143.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Member Conflict Review, PA 07-318.''
Contact Person for More Information: Bernadine Kuchinski, PhD,
Scientific Review Officer, Office of Extramural Programs, NIOSH,
CDC, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C-7,
Cincinnati, Ohio 45226, Telephone: (513) 533-8511.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Dated: August 12, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-21420 Filed 8-19-11; 8:45 am]
BILLING CODE 4163-18-P